NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AZACITIDINE-TEVA® V1.0 08072019 Powder for Injection (azacitidine 100 mg) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Azacitidine-Teva. It does…
Read More
Methoblastin PFS
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. METHOBLASTIN® PFS methotrexate (meth-o-TREX-ate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about METHOBLASTIN® PFS. It does not contain all the…
Read More
Ciprofloxacin Alphapharm
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CIPROFLOXACIN ALPHAPHARM ciprofloxacin CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about CIPROFLOXACIN ALPHAPHARM. It does not contain all the available…
Read More
Bone density loss from Anastrozole partially reverses after treatment stops
A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole partially reverses, particularly at the lumbar spine, after stopping treatment. Anastrozole is…
Read More
Poor bone quality is linked to poor heart health
New research by Queen Mary University of London and the University of Southampton’s Medical Research Council Lifecourse Epidemiology Unit (MRC LEU) has found associations between lower bone mineral density and worse cardiovascular health in both men and women. Published in…
Read More
Novel therapeutic approaches for aggressive bone cancer
Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study led by geneticist Erwin Wagner has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic and treatment strategies…
Read More
New biomaterial has potential to repair damaged bone with lower risk of inflammation
Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation. The study, conducted by…
Read More
How lockdown impacts those with bone, joint and muscle pain
University of East Anglia researchers are launching a new study to see how COVID-19 and lockdown are affecting people with bone, joint and muscle pain. Their previous research has revealed the challenges and poor health outcomes caused by social isolation…
Read More
Injectable drug for faster healing of bone fractures prepares for clinical trials
One in three adults aged 60 and over suffering from a hip fracture dies within one year. Now, a Purdue University-affiliated startup is moving closer to the start of clinical trials for a novel injectable drug that is targeted to…
Read More
Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel…
Read More